Currently:
John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH next week. He’s posted his slides and some background readings on his web site at http://www.ceruleanllc.com/NIH/. These materials will only be available until April 25th, so hurry on over and read them.
The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th launch at BIO 2009. One of the objectives for the project was to put marketing-speak aside and objectively measure biotechnology innovation progress around the world. Going beyond gross regional measures, we compare individual countries to [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2009
*Drugs may be covered by multiple patents
Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not so, if history decides to repeat itself.
Roche has already bought (and sold) Genentech once before. It’s not unimaginable to think that they’re using the current economic crisis to do another value-based flip. Using an excerpt [...]
I’ll be giving a talk at the Johns Hopkins Carey Business School Entrepreneurship Conference on March 21st titled “Entrepreneurship: What Not to Do.” The talk will cover cases in failed entrepreneurship in biotechnology, elucidating some of the forseeable and unforseeable factors which can lead to failure.
Hope to see some readers there. If you can’t make [...]
The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited by Arlen Meyers.
The links below will take you to the abstract for each paper:
Volume 15, Issue 2
Editorial
Arlen Meyers
The implementation of a proseminar course to lead change in the MS.MBA biotechnology programme at Johns Hopkins University
Lynn [...]
Reach a targeted audience with BiotechBlog.
Advertising opportunities are available on BiotechBlog. BiotechBlog is syndicated by BlogBurst, which means that posts are syndicated to outlets such as Reuters, Biospace, San Francisco Gate, and dozens of other media outlets, ensuring a large audience for your message.
Flexible ad spots are available to suit your needs, from simple text [...]
Did you know that BiotechBlog posts are syndicated to outlets such as Reuters, Biospace, San Francisco Gate, Chicago Sun-Times, and dozens of other media outlets? BiotechBlog provides a forum to promote your expertise through the publication of actionable industry guidance. See guest content and the submission guidelines for more information
THiCK by
